Today: 22 March 2026
Browse Category

Stock Market 31 December 2025

Ekso Bionics (EKSO) stock slips premarket after ChronoScale AI deal-fueled surge

Ekso Bionics (EKSO) stock slips premarket after ChronoScale AI deal-fueled surge

Ekso Bionics shares fell 8.3% to $9.70 premarket after surging 93.8% Tuesday, following Applied Digital’s plan to merge its cloud unit with Ekso to form ChronoScale. The companies signed a non-binding term sheet, with Applied Digital set to own about 97% of the combined firm. Investors await binding terms, financing details, and SEC filings ahead of a shareholder vote.
AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

Aimei Health Technology shares jumped 38% to $114 in premarket trading Wednesday, after closing up 89% at $82.58 Tuesday. The surge follows a sharp reduction in outstanding shares after nearly 4 million were redeemed this month, leaving about 2.18 million shares. Trading volume Tuesday was four times the recent average. The company faces a Jan. 6, 2026, deadline to complete its merger with United Hydrogen Group.
31 December 2025
Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Profusa shares fell about 12% to 10.7 cents in premarket trading Wednesday after a 78% surge the previous day. The company raised the conversion floor on its senior secured convertible notes to $0.35 and eliminated mandatory amortization payments. A filing outlined conditions for up to $5 million in new note financing and referenced a possible reverse stock split in January 2026.
31 December 2025
Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Vanda Pharmaceuticals shares rose about 18% in premarket trading after the FDA approved its motion-sickness drug Nereus (tradipitant). The company plans to launch the oral treatment in the coming months. The approval followed late-stage trials involving 681 patients. Shares closed at $7.03 Tuesday and were indicated around $8.30 early Wednesday.
NIO stock steadies in premarket as China rolls out 2026 trade-in subsidies for EVs

NIO stock steadies in premarket as China rolls out 2026 trade-in subsidies for EVs

NIO’s U.S.-listed shares closed up 3% at $5.50 Tuesday on heavy volume, then held steady in early premarket trade as Beijing announced new consumer subsidies for 2026, including up to 20,000 yuan for scrapping old cars and buying new energy vehicles. President Xi Jinping pledged more proactive macro policies next year. XPeng and Li Auto shares also rose.
Stock Market Today: S&P 500 futures slip on New Year’s Eve as Meta’s Manus deal fuels AI chatter

Stock Market Today: S&P 500 futures slip on New Year’s Eve as Meta’s Manus deal fuels AI chatter

S&P 500, Nasdaq 100, and Dow futures slipped early Wednesday, with S&P 500 futures down 0.23% by 2:18 a.m. ET. Meta agreed to acquire Singapore-based AI startup Manus for over $2 billion, according to the Wall Street Journal. Apple and Nvidia led losses among big tech, while energy stocks outperformed. Investors await weekly jobless claims and year-end portfolio rebalancing.
AI stocks today: Nvidia’s China H200 chip rush puts chipmakers in focus before New Year trade

AI stocks today: Nvidia’s China H200 chip rush puts chipmakers in focus before New Year trade

Nvidia has asked TSMC to increase production of its H200 AI chips as Chinese firms ordered over 2 million units for 2026, far above Nvidia’s inventory, sources told Reuters. TSMC may ramp up output in Q2 2026 if China approves imports after new U.S. export rules. Nvidia shares fell 0.3% Tuesday. ByteDance plans to spend $14.3 billion on Nvidia chips in 2026, according to the South China Morning Post.
EQT stock wobbles premarket as U.S. natural gas futures slide after weather-driven rally

EQT stock wobbles premarket as U.S. natural gas futures slide after weather-driven rally

U.S. natural gas futures fell about 4% early Wednesday to $3.81/mmBtu after a recent surge on colder forecasts and record LNG export demand. EQT Corp shares slipped 0.5% in extended trading, last quoted at $54.36. Average gas flows to U.S. LNG export plants hit 18.5 bcfd so far in December, topping November’s record, LSEG data showed. Investors are watching winter forecasts and upcoming February earnings reports.
Dow Jones today: Fed minutes and thin liquidity set the tone for 2025’s final session

Dow Jones today: Fed minutes and thin liquidity set the tone for 2025’s final session

The Dow closed down 94.87 points, or 0.20%, at 48,367.06 in thin holiday trading Tuesday. Federal Reserve minutes showed policymakers split after a quarter-point rate cut, keeping attention on the 2026 rate outlook. Boeing secured an $8.6 billion Pentagon contract tied to the F-15 Israel Program. U.S. bond markets will close early at 2 p.m. ET Wednesday; stocks are shut Thursday for New Year’s Day.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 31.12.2025

Tractor Supply raised its dividend by 4.5% in February but underperformed in 2025, offering a 1.8% yield and 44% payout ratio. India's Sensex and Nifty closed higher on renewed metal stock buying after new steel import duties; US shares fell. CAPREIT trades 30% below its peak, with a 4.2% yield. Orora shares dropped 23% in three years as earnings lagged the market.
31 December 2025
Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Newmont shares rose 2.1% to $101.86 Tuesday, rebounding as gold prices recovered after a sharp drop tied to higher futures margin requirements. Spot gold climbed 0.8% to $4,364.70 an ounce, while U.S. gold futures settled 1% higher. Raymond James raised its Newmont price target to $111 and kept an Outperform rating. Peers Agnico Eagle Mines and AngloGold Ashanti also advanced.
31 December 2025
Constellation Energy stock slips today as Calpine deal steps and nuclear AI demand stay in focus

Constellation Energy stock slips today as Calpine deal steps and nuclear AI demand stay in focus

Constellation Energy closed down 0.4% at $357.12 Tuesday as traders tracked its $26.6 billion Calpine acquisition and regulatory hurdles, including required divestitures in three states. Shares moved between $355.50 and $361.40. No new filings followed a Dec. 23 update on Calpine note exchanges. Nuclear power sentiment remained in focus after Duke Energy’s permit application for a new North Carolina facility.
Lockheed Martin stock today dips despite $500 million Pentagon contract flow for Aegis, THAAD work

Lockheed Martin stock today dips despite $500 million Pentagon contract flow for Aegis, THAAD work

Lockheed Martin shares closed down 0.18% at $488.00 Tuesday after the Pentagon announced about $500 million in contract modifications for Aegis ship systems and THAAD missile-defense support. The largest was a $297.5 million award for Aegis sustainment. The S&P 500 slipped 0.14%. Investors await Lockheed’s late-January earnings and early-2026 U.S. defense budget news.
ConocoPhillips stock rises as oil steadies; Australia gas well update and Feb. 5 earnings in focus

ConocoPhillips stock rises as oil steadies; Australia gas well update and Feb. 5 earnings in focus

ConocoPhillips shares rose 1.6% to $94.10 Tuesday after a partner reported drilling at the Charlemont-1 well offshore Australia was paused due to unexpected gas shows and higher-than-forecast pressures. Oil prices closed little changed, while the S&P 500 slipped 0.14%. ConocoPhillips will release fourth-quarter results and 2026 guidance on Feb. 5.

Stock Market Today

  • Australia Shares Expected to Decline at Open, New Zealand Markets Fall
    March 22, 2026, 6:45 PM EDT. Australian shares are forecast to open lower amid regional market pressures, with New Zealand's market also declining. Investors remain cautious as global economic indicators weigh on sentiment. The Australian Securities Exchange (ASX) is set to follow the downtrend seen in other Asia-Pacific markets, reflecting concerns over growth prospects. New Zealand's benchmark index has retreated, pressured by similar factors. Traders are monitoring external influences, including commodity prices and currency fluctuations, ahead of key economic data releases. The outlook remains uncertain as markets adjust to ongoing geopolitical and economic developments.
Go toTop